These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33021155)

  • 61. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.
    Chung YR; Kim HJ; Jang MH; Park SY
    Breast Cancer Res Treat; 2017 Feb; 161(3):409-420. PubMed ID: 27913931
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses.
    Yu G; Dai H; Chen J; Duan L; Gong M; Liu L; Xiong P; Wang CY; Fang M; Gong F
    J Gene Med; 2008 Jul; 10(7):754-61. PubMed ID: 18452241
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors.
    Holmgaard RB; Zamarin D; Lesokhin A; Merghoub T; Wolchok JD
    EBioMedicine; 2016 Apr; 6():50-58. PubMed ID: 27211548
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antigen expression in canine tissues, recognized by a monoclonal antibody generated against canine melanoma cells.
    Oliver JL; Wolfe LG
    Am J Vet Res; 1992 Jan; 53(1):123-8. PubMed ID: 1539903
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Association of CD8+ Cytotoxic T Cells and Granzyme B+ Lymphocytes with Immunosuppressive Factors, Tumor Stage and Prognosis in Cutaneous Melanoma.
    Salmi S; Hälinen K; Lin A; Suikkanen S; Jokelainen O; Rahunen E; Siiskonen H; Pasonen-Seppänen S
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551965
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of tumour-infiltrating regulatory T cells with adverse outcomes in dogs with malignant tumours.
    Sakai K; Maeda S; Yamada Y; Chambers JK; Uchida K; Nakayama H; Yonezawa T; Matsuki N
    Vet Comp Oncol; 2018 Sep; 16(3):330-336. PubMed ID: 29322606
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.
    Laimer K; Troester B; Kloss F; Schafer G; Obrist P; Perathoner A; Laimer J; Brandacher G; Rasse M; Margreiter R; Amberger A
    Oral Oncol; 2011 May; 47(5):352-7. PubMed ID: 21440489
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Review of the comparative pathological and immunohistochemical features of human and canine cutaneous melanocytic neoplasms.
    Contel IJ; Fonseca-Alves CE; Ferrari HF; Laufer-Amorim R; Xavier-Júnior JCC
    J Comp Pathol; 2024 May; 211():26-35. PubMed ID: 38761560
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma.
    Wei YF; Chu CY; Chang CC; Lin SH; Su WC; Tseng YL; Lin CC; Yen YT
    Lung Cancer; 2018 Nov; 125():35-42. PubMed ID: 30429036
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Canine melanoma diagnosis: RACK1 as a potential biological marker.
    Campagne C; Julé S; Alleaume C; Bernex F; Ezagal J; Château-Joubert S; Estrada M; Aubin-Houzelstein G; Panthier JJ; Egidy G
    Vet Pathol; 2013 Nov; 50(6):1083-90. PubMed ID: 23735618
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanoma.
    Chen D; Koropatnick J; Jiang N; Zheng X; Zhang X; Wang H; Yuan K; Siu KS; Shunnar A; Way C; Min WP
    J Immunother; 2014; 37(2):123-34. PubMed ID: 24509175
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression.
    Bongiovanni L; D'Andrea A; Porcellato I; Ciccarelli A; Malatesta D; Romanucci M; Della Salda L; Mechelli L; Brachelente C
    Vet Dermatol; 2015 Aug; 26(4):270-e59. PubMed ID: 25962968
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.
    Roy S; Barik S; Banerjee S; Bhuniya A; Pal S; Basu P; Biswas J; Goswami S; Chakraborty T; Bose A; Baral R
    Hum Immunol; 2013 Aug; 74(8):1015-23. PubMed ID: 23628394
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway.
    Cribbs AP; Kennedy A; Penn H; Read JE; Amjadi P; Green P; Syed K; Manka SW; Brennan FM; Gregory B; Williams RO
    Arthritis Rheumatol; 2014 Sep; 66(9):2344-54. PubMed ID: 24891289
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ganoderic acid Me induces the apoptosis of competent T cells and increases the proportion of Treg cells through enhancing the expression and activation of indoleamine 2,3-dioxygenase in mouse lewis lung cancer cells.
    Que Z; Zou F; Zhang A; Zheng Y; Bi L; Zhong J; Tian J; Liu J
    Int Immunopharmacol; 2014 Nov; 23(1):192-204. PubMed ID: 25138378
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Targeting CTLA-4, PD-L1 and IDO to modulate immune responses in vitiligo.
    Speeckaert R; van Geel N
    Exp Dermatol; 2017 Jul; 26(7):630-634. PubMed ID: 27192950
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.
    Millanta F; Fratini F; Corazza M; Castagnaro M; Zappulli V; Poli A
    Res Vet Sci; 2002 Aug; 73(1):45-51. PubMed ID: 12208106
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cyclooxygenase-2 expression is related with localization, proliferation, and overall survival in canine melanocytic neoplasms.
    Martínez CM; Peñafiel-Verdú C; Vilafranca M; Ramírez G; Méndez-Gallego M; Buendía AJ; Sánchez J
    Vet Pathol; 2011 Nov; 48(6):1204-11. PubMed ID: 21292918
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases.
    Mourmouras V; Fimiani M; Rubegni P; Epistolato MC; Malagnino V; Cardone C; Cosci E; Nisi MC; Miracco C
    Br J Dermatol; 2007 Sep; 157(3):531-9. PubMed ID: 17596146
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance.
    Sandri S; Watanabe LRM; Oliveira EA; Faião-Flores F; Migliorini S; Tiago M; Felipe-Silva A; Vazquez VL; da Costa Souza P; Consolaro MEL; Campa A; Maria-Engler SS
    Pharmacol Res; 2020 Sep; 159():104998. PubMed ID: 32535222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.